Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis. (Q42283057)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Sarah P Hammond

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Francisco M. Marty

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

9

L R Baden

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

S T Martin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

K Roberts

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

A L Fuhlbrigge

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

P C Camp

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

H J Goldberg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

1 reference

12 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

Transplant Infectious Disease

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

163-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

Infection in organ-transplant recipients

20 February 2020

cites work

1 reference

A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients.

21 January 2018

1 reference

Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation

21 January 2018

1 reference

An international survey of cytomegalovirus management practices in lung transplantation

21 January 2018

1 reference

Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy.

21 January 2018

1 reference

Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation

21 January 2018

1 reference

Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial

21 January 2018

1 reference

Long-term efficacy and safety of 12 months of valganciclovir prophylaxis compared with 3 months after lung transplantation: a single-center, long-term follow-up analysis from a randomized, controlled cytomegalovirus prevention trial.

21 January 2018

1 reference

Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis

21 January 2018

1 reference

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

21 January 2018

1 reference

Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection

21 January 2018

1 reference

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria

21 January 2018

1 reference

American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation

21 January 2018

1 reference

Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation.

21 January 2018

1 reference

A Targeted Peritransplant Antifungal Strategy for the Prevention of Invasive Fungal Disease After Lung Transplantation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TID.12036

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23230972%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference